To increase development productivity, the industry must put its faith in leaders that understand the science behind innovation, says Dana Krueger...
Companies are looking to artificial intelligence for new ways to improve their efficiencies and success rates
New proposals should help patients get innovative drugs faster, but will the new CDF be too reliant on pharma companies offering discounts?
Pharmafocus asks: Why is it so difficult to develop a cheap ultra-orphan drug, and where are the opportunities to do so in pharma?
Embattled company may have steadied the ship with an interim boss, but future success could hinge on events beyond its control
Is there an argment for using adaptive trials as a methodology to research dementia?
We predict what the industry can expect to see in the New Year
With a 135-year-old chemical, Provectus says it is advancing a new front in the war against cancer - and big pharma seems to agree
The executive director of the Access to Medicine Foundation tells Pharmafile.com only one in three pharma companies has credible pricing...
Fritz Sacher, the company’s head of Africa strategy realisation, explains how the company will double its presence on the continent by 2020